Bausch + Lomb Corporation (BLCO)

USD 18.24

(-3.24%)

Total Debt Summary of Bausch + Lomb Corporation

  • Bausch + Lomb Corporation's latest annual total debt in 2023 was 4.56 Billion USD , up 87.27% from previous year.
  • Bausch + Lomb Corporation's latest quarterly total debt in 2024 Q3 was 4.62 Billion USD , down -0.06% from previous quarter.
  • Bausch + Lomb Corporation reported annual total debt of 2.43 Billion USD in 2022, up 2075.0% from previous year.
  • Bausch + Lomb Corporation reported annual total debt of 112 Million USD in 2021, up 10.89% from previous year.
  • Bausch + Lomb Corporation reported quarterly total debt of 4.63 Billion USD for 2024 Q2, up 1.05% from previous quarter.
  • Bausch + Lomb Corporation reported quarterly total debt of 4.58 Billion USD for 2024 Q1, up 0.48% from previous quarter.

Annual Total Debt Chart of Bausch + Lomb Corporation (2023 - 2019)

Historical Annual Total Debt of Bausch + Lomb Corporation (2023 - 2019)

Year Total Debt Total Debt Growth
2023 4.56 Billion USD 87.27%
2022 2.43 Billion USD 2075.0%
2021 112 Million USD 10.89%
2020 101 Million USD 8.6%
2019 93 Million USD 0.0%

Peer Total Debt Comparison of Bausch + Lomb Corporation

Name Total Debt Total Debt Difference
Alcon Inc. 5.14 Billion USD 11.301%
AptarGroup, Inc. 1.18 Billion USD -285.085%
Baxter International Inc. 14.36 Billion USD 68.24%
Becton, Dickinson and Company 15.87 Billion USD 71.27%
Haemonetics Corporation 873.88 Million USD -422.037%
Envista Holdings Corp 1.65 Billion USD -175.883%
ResMed Inc. 873.93 Million USD -422.007%
Teleflex Incorporated 1.92 Billion USD -136.818%
Warby Parker Inc. 174.45 Million USD -2514.971%
West Pharmaceutical Services, Inc. 309 Million USD -1376.375%